Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0002600Phase 4Recruiting
A Phase 4 trial of levothyroxine sodium, liothyronine in hypothyroidism, thyroid neoplasm, sponsored by Dalim Biotech. Started Apr 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0002600.